Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2012
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108594 PROCESS FOR PREPARING SALTS OF 4-[[5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL]AMINO]-5-METHYL-N-PROPYLPYRROLO[2,1-f][1,2,4]TRIAZINE-6-CARBOXAMIDE AND NOVEL STABLE FORMS PRODUCED THEREIN
05/03/2012US20120108590 Melt-extruded solid dispersions containing an apoptosis-inducing agent
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108584 2h or 3h-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108582 Fused substituted aminopyrrolidine derivative
05/03/2012US20120108578 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108534 Dihydrothienopyrimidines for the treatment of inflammatory Diseases
05/03/2012US20120108529 Protease inhibitors
05/03/2012US20120108528 New therapeutic approaches for treating neuroinflammatory conditions
05/03/2012US20120108524 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
05/03/2012US20120108509 Artificial scab for use in an airway
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107846 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
05/03/2012US20120107390 Feline infectious peritonitis vaccine
05/03/2012US20120107364 Antibody having anti-cancer activity
05/03/2012US20120107360 Gamma-glutamyl transpeptidase attenuated francisella
05/03/2012US20120107359 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
05/03/2012US20120107358 Subgenomic replicons of the flavivirus dengue
05/03/2012US20120107353 Composition
05/03/2012US20120107352 Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians
05/03/2012US20120107351 In Ovo Vaccination of Campylobacter in Avian Species
05/03/2012US20120107350 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
05/03/2012US20120107348 Multivalent pcv2 immunogenic compositions and methods of producing such compositions
05/03/2012US20120107346 Combination vaccines with low does of hib conjugate
05/03/2012US20120107343 Production of recombinant proteins in ciliates and uses thereof
05/03/2012US20120107342 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
05/03/2012US20120107341 Methods for producing an immune response to tuberculosis
05/03/2012US20120107340 Compositions for immunising against staphylococcus aureus
05/03/2012US20120107339 Chimeric Factor H Binding Proteins (fHBP) Containing a Heterologous B Domain and Methods of Use
05/03/2012US20120107338 Identification of a novel retrovirus in patients with benign prostatic hyperplasia
05/03/2012US20120107337 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (hla) class i or class ii molecules for vaccines
05/03/2012US20120107336 Modified defensins and their use
05/03/2012US20120107335 Synthetic Oligopeptides Designed From Mite Cysteine Proteases and Methods for the Production of
05/03/2012US20120107334 Method for enhancing immune response with peptide
05/03/2012US20120107333 Vangl1 peptides and vaccines including the same
05/03/2012US20120107332 Beta-Glucuronide-Linker Drug Conjugates
05/03/2012US20120107329 EGFR and PAR2 Regulation of Intestinal Permeability
05/03/2012US20120107327 Immunogenic compositions of staphylococcus aureus antigens
05/03/2012US20120107322 Immunogenic and therapeutic compositions for streptococcus pyogenes
05/03/2012US20120107321 Antibodies And Epitopes Specific To Misfolded Prion Protein
05/03/2012US20120107317 Use of cytoplasmic c-myc for regulating immune responses
05/03/2012US20120107313 Mammalian receptor proteins; related reagents and methods
05/03/2012US20120107301 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
05/03/2012US20120107298 Use of LCAT for Treating Anemia and Red Blood Cell Dysfunction
05/03/2012US20120107290 Non-replicating micro-organisms and their immune boosting effect
05/03/2012US20120107287 Specialized medical nutrition for surgical and trauma patients containing probiotics
05/03/2012US20120107281 Compositions and methods for modifying cell surface glycans
05/03/2012US20120107275 Fused heterocyclic derivatives and methods of use
05/03/2012US20120107273 New piperazine compound and use thereof as a hcv polymerase inhibitor
05/03/2012US20120107272 Synthetic methods and derivatives of triphosphate oligonucleotides
05/03/2012US20120107271 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
05/03/2012US20120107269 Thiophene derivatives
05/03/2012US20120107268 Lymph node-targeting nanoparticles
05/03/2012US20120107230 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs
05/03/2012DE102010050449A1 Verwendung von Etacrynsäure zur Behandlung von Lebensmittelempfindlichkeitsstörungen Use of ethacrynic acid for the treatment of food hypersensitivity disorders
05/03/2012DE102008062136B4 Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch A pharmaceutical composition based on peptide from camel milk
05/03/2012CA2816379A1 Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies
05/03/2012CA2815237A1 Method of improving transplant function using soluble complement receptor type i (scr1)
05/03/2012CA2815170A1 Pyridine derivative and medicinal agent
05/03/2012CA2814436A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
05/03/2012CA2795577A1 New compositions and methods for treatment of autoimmune and allergic diseases
05/02/2012EP2447369A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447368A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447367A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447263A1 Benzazole derivatives as histamine H4 receptor ligands
05/02/2012EP2447254A1 Crystals
05/02/2012EP2446902A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446901A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446883A1 Treatment of inflammation
05/02/2012EP2446754A1 Fermentation product of a cereal-derived material and immunomodulator
05/02/2012EP2446030A1 Synthetic operon
05/02/2012EP2445934A2 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof
05/02/2012EP2445912A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
05/02/2012EP2445892A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
05/02/2012EP2445891A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
05/02/2012EP2445537A1 Conjugates of cytotoxic drugs
05/02/2012EP2445503A1 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
05/02/2012EP2026832B1 Combination of interferon-beta and a cladribine regimen for treating multiple sclerosis
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012CN1404398B Improved DNA vaccines for production-type animals
05/02/2012CN102439153A Compositions for stimulation of mammalian innate immune resistance to pathogens
05/02/2012CN102439007A Amide derivative
05/02/2012CN102438653A Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever
05/02/2012CN102438624A Substituted fused pyrimidine compounds
05/02/2012CN102433249A Medicinal health-care liquor for resisting fatigue and improving immunity and preparation method thereof
05/02/2012CN102433248A Selenium-rich sika deer pilos antler health-preserving wine and preparation method thereof
05/02/2012CN102432599A Crystal form of oxalate of dipeptidyl peptidase inhibitor and preparation method and application thereof
05/02/2012CN102430128A Application of signal-regulatory protein alpha (SIRPalpha) in preparation of medicines for preventing and treating allergic diseases
05/02/2012CN102430120A Adjuvant for enhancing fish vaccine immunization effect and application thereof
05/02/2012CN102430110A CAlprostadil composite medicament of compound fermented cordyceps sinensis powder and alprostadil composite drug
05/02/2012CN102430089A Method for preparing ultrafine powder Qiangzhuang San at normal temperature and special bidirectional airflow sieving machine
05/02/2012CN102430086A Traditional Chinese medicine composition with function of tonifying qi of kidneys and preparation method thereof
05/02/2012CN102430082A Traditional Chinese medicine sachet and preparation method thereof
05/02/2012CN102430058A Composition for improving immunity